supported by the Capital's Funds for Health Improvement and Research(No.2024-1G-4023);the National Natural Science Foundation of China(No.82273721)。
Objective:Data on the global,regional and national changes in the trends of colorectal cancer(CRC)are analyzed to understand the trends in its burden,in order to assist policymakers in allocating healthcare resources ...
supported by the Beijing Medical Award Foundation(No.YXJL-2023-0670-0150)。
Objective:Colorectal cancer(CRC)surgeries can be performed using either laparoscopic or open laparotomy approaches.However,the long-term outcomes based on tumor location and age remain unclear.This study compared the ...
funded by the National Natural Science Foundation of China(No.82060453,82103645 and 82260596);the Natural Science Foundation of Jiangxi Province(No.20242BAB25506);the China Postdoctoral Science Foundation(No.2023M741523)。
As a key component of tumor microenvironment,the microbiota has gradually played a key role in cancer research.Particularly in colorectal cancer,the specific population of microbiota within the tumor shows a strong as...
supported by the Program of National Science Fund for Distinguished Young Scholars of China(No.81925032);Key Program of National Natural Science Foundation of China(No.82130098);National Natural Science Foundation of China(No.82304232)。
Objective: Genome-wide association studies(GWAS) have identified over 150 risk loci linked to colorectal cancer(CRC), including the 17p13.3 locus with the tag single nucleotide polymorphism(SNP) rs12603526 in the Asia...
supported by grants from Sanming Project of Medicine in Shenzhen(No.SZSM202211017);Shenzhen Key Medical Discipline Construction Fund(No.SZXK014).
Although there has been significant advancement in the identification and management of colorectal cancer(CRC)in recent years,there is still room for improvement in the current standard treatment regimen.One area of c...
supported by the Provincial Key R&D Program of Zhejiang Province(No.2021C03125);National Natural Science Foundation of China(No.82373415 and No.82302489);Beijing Xisike Clinical Oncology Research Foundation(No.Y-tongshu2021/ms-0003).
According to the latest global cancer statistics,colorectal cancer(CRC)is the most common malignancy of the digestive system and the second most lethal among all cancer types(1).In China,CRC is the second most prevale...
supported by “San Ming” Project of Shenzhen, China (No. SZSM201612051);National Natural Science Foundation of China (No. 81972240)。
Colorectal cancer has a high incidence and mortality rate in China, with the majority of cases being middle and low rectal cancer. Surgical intervention is currently the main treatment modality for locally advanced re...
The prevalence of colorectal cancer(CRC) is increasing annually and metastasis is the principal cause of death in patients with CRC, with the liver being the most frequently affected site. Many studies have shown a st...
China ranks the first worldwide in the number of new colorectal cancer(CRC) cases and CRC-related deaths. The increasing incidence of early-onset CRC in recent years highlights the challenges related to CRC screening ...
Colorectal cancer(CRC)has always been one of the most common malignant tumors in the world,and the incidence and mortality have been on the rise in China.The Cancer Statistics Report of China in 2020 showed that the i...